Elan considers selling division
Comments
By jan ronk | Posted 10:20pm | July 22, 2008
when is someone going to restore the old mysoline 250 mg. tablet formula? patients are reporting problems with the new formula. this medication worked. the new meds are not working. why fix what is not broken? or caused law suits and birth defects?
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
